HOME > NEW FUNDS > Genesys Capital
New Fund Icon New Fund

Genesys Capital

Canada-based Genesys Capital launched a fund with a first close over $30M targeting up to $40M to back early-stage life sciences startups translating university research across biotechnology, pharmaceuticals, and medical technology.


Recent funds in Eastern US

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.